Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04673292 · ClinicalTrials.gov registry record · NA
Community Collaboration to Combat COVID-19 (C-FORWARD)
A NA study of Corona Virus Infection, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 831
- Enrollment target
- 1
- Study location
NCT04673292: Completed NA study of Corona Virus Infection, sponsored by Johns Hopkins University.
NCT04673292 is a NA study of Corona Virus Infection that has completed, run by Johns Hopkins University. The registered enrollment target is 831 participants, above the 556-participant average among 28 other Corona Virus Infection trials with a reported enrollment target (49% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04673292, a NA study of Corona Virus Infection, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 831 participants
- Enrollment target
- 1
- Study location
Study Summary
This is randomized trial where households will be randomized to identify the optimal SARS-CoV-2 (COVID-19) testing modality in a population-representative sample of households in Baltimore City, Maryland. 1,386 households in Baltimore City will be randomized 1:1:1 to one of three testing modalities: 1) fixed-site standard of care testing; 2) community-based mobile van testing; or 3) self-collected home, based testing.
Primary Outcome
Uptake of SARS CoV-2 testing will be assessed by proportion of participants who are randomized and complete SARS CoV-2 testing.
Conditions Studied
Interventions
- BEHAVIORAL Fixed site standard of care testing
- BEHAVIORAL Community-based, mobile van testing
- BEHAVIORAL Self-collected, home-based testing
Study Locations (1)
Maryland
- 2212 McElderry Street - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 831 participants |
| Start Date | 2021-02-08 |
| Est. Completion | 2023-06-09 |
| Phase | NA |
What the finished NCT04673292 record still lists
NCT04673292 is an interventional study that assigns participants to a tested intervention. The registered 831 participants enrollment target is mid-sized for trials with a published cap, above the 556-participant average among 28 other Corona Virus Infection trials with a reported enrollment target (49% higher).
The record links to 1 condition, with Corona Virus Infection appearing as the primary indexed condition, and to 3 interventions - of which Fixed site standard of care testing is the first listed.
NCT04673292 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT04673292 about?
NCT04673292 is a clinical study titled "Community Collaboration to Combat COVID-19 (C-FORWARD)". This is randomized trial where households will be randomized to identify the optimal SARS-CoV-2 (COVID-19) testing modality in a population-representative sample of households in Baltimore City, Maryland. 1,386 households in Baltimore City will be randomized 1:1:1 to one of three testing modalities:...
What is the current status of trial NCT04673292?
This trial is currently completed. It is a NA study. The enrollment target is 831 participants. The study started on 2021-02-08. Estimated completion is 2023-06-09.
What conditions does trial NCT04673292 study?
This clinical trial studies the following conditions: Corona Virus Infection.
What interventions are being tested in trial NCT04673292?
The interventions under investigation include: Fixed site standard of care testing (BEHAVIORAL), Community-based, mobile van testing (BEHAVIORAL), Self-collected, home-based testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT04673292?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04673292 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Corona Virus Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04673292's enrollment target sits among peer trials
831 4th of 28 higher than 25 of 28 other Corona Virus Infection trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Corona Virus Infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study To Evaluate The Performance of the Lucira Health All-In-One COVID-19 Test Kit vs Hologic Panther Fusion
COMPLETED · NA
-
Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS
COMPLETED · NA
-
A Follow On Community Testing Study To Evaluate The Performance of the Lucira COVID-19 All-In-One Test Kit
COMPLETED · NA
-
Computer Cognitive Training for Post-acute COVID-19 Syndrome
COMPLETED · NA
-
Photo-Protection Trial (NB-UVB vs. Placebo) in High-risk Hospitalized COVID-19 Patients
COMPLETED · NA
-
Assessment of N-95 Facemask for Use in COVID-19 Pandemic in Case of Shortage of Personal Protective Equipment
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06910553 · 832 participants
IBD Pregnancy Registry
- NCT07089706 · 832 participants · Phase 4
A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations
- NCT05067283 · 830 participants · Phase 1
A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)
- NCT06592924 · 830 participants · Phase 3
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI